Young Woman With Breast Cancer and Cardiotoxicity With Severe Heart Failure Treated With a HeartMate II (TM) for Nearly 6 Years Before Heart Transplantation
2014 (English)In: ASAIO journal (1992), ISSN 1058-2916, E-ISSN 1538-943X, Vol. 60, no 6, E3-E4 p.Article in journal (Refereed) Published
Cardiotoxicity is a multifactorial problem, which has emerged with the improvement of cancer therapies and survival. Heart transplantation is relatively contraindicated in patients with breast cancer, until at least 5 years after complete remission. We present a case where a young woman who in 2001, at the age of 31, was diagnosed with breast cancer. She was considered cured, but 4 years later she suffered a relapse. During her second treatment, in 2006, she suffered from severe heart failure. She received a HeartMate II, as a long-term bridge to transplantation and 6 years later she was successfully transplanted. In this case report we discuss the use of mechanical circulatory support in cancer patients with drug-induced heart failure.
Place, publisher, year, edition, pages
Lippincott, Williams andamp; Wilkins , 2014. Vol. 60, no 6, E3-E4 p.
breast cancer; cardiotoxicity; heart failure; mechanical circulatory support; heart transplantation
IdentifiersURN: urn:nbn:se:liu:diva-113018DOI: 10.1097/MAT.0000000000000138ISI: 000345299200001PubMedID: 25232773OAI: oai:DiVA.org:liu-113018DiVA: diva2:778948